# Indiana University Comprehensive Training in Clinical Pharmacology

> **NIH NIH T32** · INDIANA UNIVERSITY INDIANAPOLIS · 2024 · $565,977

## Abstract

There is a critical need of well-trained clinical scientist that can augment the translation of new therapies into
clinical practice and to ensure the safe and effective use of medications. The Indiana University
Comprehensive Training Program in Clinical Pharmacology (T32GM008425), currently in the 29th year and
trained over 50 scientists in clinical pharmacology, seeks to continue preparing fellows (MDs, PharmDs,
PharmD/PhDs, DNPs, MD/PhDs, PhDs or equivalent) for careers in translational and clinical therapeutics.
Fellows have access to 40 committed, vibrant, and multidisciplinary participating faculty drawn from a broad
range of basic and clinical therapeutics research programs (25 preceptors selected based on research quality,
peer-reviewed funding, collaborative relationships, and mentoring commitment, and 15 participating in other
roles). Trainees conduct research (laboratory, clinical and/or in silico) under the mentorship of one of the
preceptors. Collaborations among the preceptors include pharmacogenomics, adverse drug reactions, drug-
drug interactions, drug disposition, drug discovery and development, quantitative pharmacology, pediatric
pharmacology, precision medicine, biomarker of drug response and therapeutic outcomes. Trainees will also
receive formal training in broad clinical pharmacology issues and skills and in research ethics and responsible
conduct of research to prepare trainees for the complexities involved in the research and practice of
translational therapeutics. Fellows attend team journal clubs specifically organized to break down silos twice
monthly, seminars in clinical pharmacology and personalized medicine every week, and an organized didactic
program every week. The didactic training concentrates on PK/PD, drug and metabolite analysis,
pharmacogenomics, quantitative pharmacology, biostatistics, clinical trial design, drug discovery and
development, research ethics and the responsible conduct of research. The training occurs in an exceptionally
rich, synergetic, and complementary training environment. The institutional support to strengthen the Division
and its training program is outstanding. The training program continues to generate diverse clinical
pharmacologists, including women and underrepresented minorities, who have assumed prominent roles in
academia, the pharmaceutical industry, and regulatory agencies. Qualified applicants have always filled the
training grant slots. In fact, we receive substantially more qualified applicants than available positions. Our
program is accredited by the American Board of Clinical Pharmacology. Because the Division of Clinical
Pharmacology at Indiana University has a long and distinguished record of excellence in training leaders in
clinical pharmacology and translational therapeutics and our training program currently represents one of the
strongest, most comprehensive, and cutting-edge training, we are in a unique position to successfully continue
training outstanding...

## Key facts

- **NIH application ID:** 10814135
- **Project number:** 5T32GM008425-32
- **Recipient organization:** INDIANA UNIVERSITY INDIANAPOLIS
- **Principal Investigator:** Zeruesenay Desta
- **Activity code:** T32 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2024
- **Award amount:** $565,977
- **Award type:** 5
- **Project period:** 1992-07-01 → 2028-06-30

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/10814135

## Citation

> US National Institutes of Health, RePORTER application 10814135, Indiana University Comprehensive Training in Clinical Pharmacology (5T32GM008425-32). Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/grant/nih/10814135. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*